These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 29069682)
21. [The need for psychopharmacologic therapy of drug addicts with acute hepatitis]. Rizzo F Clin Ter; 1984 Oct; 111(1):69-73. PubMed ID: 6149840 [No Abstract] [Full Text] [Related]
22. The neurobiology of craving: implications for the understanding and treatment of addiction. Wise RA J Abnorm Psychol; 1988 May; 97(2):118-32. PubMed ID: 3290303 [No Abstract] [Full Text] [Related]
23. Pharmacotherapy for adolescents with psychoactive substance use disorders. Kaminer Y NIDA Res Monogr; 1995; 156():291-324. PubMed ID: 8594475 [No Abstract] [Full Text] [Related]
24. Importance of construct validity in functional neuroimaging of craving. Thayer RE; Weiland BJ Addiction; 2015 Feb; 110(2):206-7. PubMed ID: 25602041 [No Abstract] [Full Text] [Related]
25. [Psychosocial conditions of psychotropic drug poisoning of patients treated in the Gdańsk Toxicology Center]. Zegarski W; Swica P; Lamparska E; Zieliński D; Bakuła S Przegl Lek; 1990; 47(6):500-1. PubMed ID: 2259735 [TBL] [Abstract][Full Text] [Related]
26. Individual differences in acute effects of drugs in humans: their relevance to risk for abuse. de Wit H NIDA Res Monogr; 1998 Mar; 169():176-87. PubMed ID: 9686416 [No Abstract] [Full Text] [Related]
27. Considerations in using psychotropic medication with dual diagnosis patients in recovery. Zweben JE; Smith DE J Psychoactive Drugs; 1989; 21(2):221-8. PubMed ID: 2668486 [TBL] [Abstract][Full Text] [Related]
28. Role of Exogenous Progesterone in the Treatment of Men and Women with Substance Use Disorders: A Narrative Review. Peltier MR; Sofuoglu M CNS Drugs; 2018 May; 32(5):421-435. PubMed ID: 29761343 [TBL] [Abstract][Full Text] [Related]
30. Correlates of compliance with psychoactive prescriptions. Apsler R; Rothman E J Psychoactive Drugs; 1984; 16(2):193-9. PubMed ID: 6470858 [No Abstract] [Full Text] [Related]
31. Anticraving medications for relapse prevention: a possible new class of psychoactive medications. O'Brien CP Am J Psychiatry; 2005 Aug; 162(8):1423-31. PubMed ID: 16055763 [TBL] [Abstract][Full Text] [Related]
32. The potential utility of some legal highs in CNS disorders. Davidson C; Schifano F Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():267-74. PubMed ID: 26232510 [TBL] [Abstract][Full Text] [Related]
33. [The use of mexidol in urgent treatment of drug addiction]. Klindukhova OI; Novgorodov OE; Sergienko NN; Daniliuk PV; Belotserkovich OV Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(11):42-5. PubMed ID: 17176602 [TBL] [Abstract][Full Text] [Related]
35. [Psychotropic drug therapy in children]. Eggers C Fortschr Med; 1977 Sep; 95(33):2028-33. PubMed ID: 334649 [No Abstract] [Full Text] [Related]
36. Stages of change for psychotropic medication adherence and substance cessation. Finnell DS; Osborne FH Arch Psychiatr Nurs; 2006 Aug; 20(4):166-74. PubMed ID: 16846777 [TBL] [Abstract][Full Text] [Related]
37. 'Tonic', 'fuel' and 'food': social and symbolic aspects of the long-term use of psychotropic drugs. Helman CG Soc Sci Med B; 1981 Oct; 15(4):521-33. PubMed ID: 6172856 [No Abstract] [Full Text] [Related]
38. New approach to the neurobiological mechanisms of addiction. Fürst Z; Riba P; Al-Khrasani M Neuropsychopharmacol Hung; 2013 Dec; 15(4):189-205. PubMed ID: 24380960 [TBL] [Abstract][Full Text] [Related]
39. Medications between psychiatric and addictive disorders. Lalanne L; Lutz PE; Trojak B; Lang JP; Kieffer BL; Bacon E Prog Neuropsychopharmacol Biol Psychiatry; 2016 Feb; 65():215-23. PubMed ID: 26514592 [TBL] [Abstract][Full Text] [Related]
40. Drug use and misuse in operant pain patients. Ziesat HA; Angle HV; Gentry WD; Ellinwood EH Addict Behav; 1979; 4(3):263-6. PubMed ID: 495250 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]